Bedel Financial Consulting, Inc. Sanofi Transaction History

Bedel Financial Consulting, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$48.99 - $57.46 $20,330 - $23,845	-415 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$48.48 - $53.65 $2,860 - $3,165	-59 Reduced 12.45%	415 $21,000
Q4 2021 Jan 11, 2022	BUY	$47.07 - $52.35 $2,777 - $3,088	59 Added 14.22%	474 $24,000
Q4 2018 Jan 28, 2019	SELL	$41.48 - $45.59 $4,148 - $4,559	-100 Reduced 19.42%	415 $18,000
Q3 2018 Nov 01, 2018	BUY	$40.0 - $44.84 $4,000 - $4,484	100 Added 24.1%	515 $22,000

Q1 2018 May 03, 2018	BUY	$38.98 - $45.76 $16,176 - $18,990	415 New	415 $17,000

757

236M

1.27M

1.57M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $125B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.